ArticleNeuropsychiatric disease and treatment2025
Blood Uric Acid in Mild Cognitive Impairment: A Cross-Sectional Study of Older Chinese Adults.
Article in Neuropsychiatric disease and treatment, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Previous studies focused on the association between uric acid (UA) as an antioxidant and cognitive impairment have been limited in scope and obtained contradictory results. Therefore, we investigated whether low blood UA levels were related to mild cognitive impairment (MCI) in a cross-sectional study. Methods: This study included 231 elderly Chinese adults 60 years and over. We used the MMSE and MoCA to evaluate cognitive function, and fasting venous blood to measure UA concentration. The relationship between blood UA and cognitive impairment was analyzed with multivariate analysis of variance, controlling for demographic information, physical exercise, lifestyle and laboratory results. Results: A total of 90 (38.96%) participants were healthy and 141 (61.04%) had MCI. Compared with the healthy group, MCI patients were more likely to have fewer years of education, inactivity and lower UA levels. UA levels were significantly lower in MCI patients than healthy individuals ( Conclusion: Lower UA levels were associated with worse cognitive function; therefore, controlling UA levels within a suitable range may slow the progression of cognitive disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.